A- A A+

Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy

Krawczyk, Noa et al.

The Lancet Public Health, Volume 8, Issue 3, e238 - e246 


The impact of the COVID-19 pandemic on access to supervised consumption programs. 

Gubskaya E, Kennedy MC, Hayashi K, Cui Z, Milloy MJ, Kerr T. 

Subst Abuse Treat Prev Policy. 2023 Mar 10;18(1):16. doi: 10.1186/s13011-023-00521-6. PMID: 36899417; PMCID: PMC9999333.


Life Habits of Healthcare Professionals during the Third Wave of COVID-19: A Cross-Sectional Study in a Spanish Hospital. 

Quiroga-Sánchez E, Calvo-Ayuso N, Liébana-Presa C, Trevissón-Redondo B, Marqués-Sánchez P, Arias-Ramos N. 

Int J Environ Res Public Health. 2023 Feb 25;20(5):4126. doi: 10.3390/ijerph20054126. PMID: 36901137; PMCID: PMC10001878.


"The new normal has become a nonstop crisis": a qualitative study of burnout among Philadelphia's harm reduction and substance use disorder treatment workers during the COVID-19 pandemic. 

Unachukwu IC, Abrams MP, Dolan A, Oyekemi K, Meisel ZF, South EC, Aronowitz SV. 

Harm Reduct J. 2023 Mar 11;20(1):32. doi: 10.1186/s12954-023-00752-7. PMID: 36906576; PMCID: PMC10008076.


The impact of the COVID-19 pandemic on mental health, associated factors and coping strategies in people living with HIV: a scoping review. 

Hong C, Queiroz A, Hoskin J. 

J Int AIDS Soc. 2023 Mar;26(3):e26060. doi: 10.1002/jia2.26060. PMID: 36912238; PMCID: PMC10009802.


Effect of the COVID-19 pandemic on adolescent mental health and substance use up to March, 2022, in Iceland: a repeated, cross-sectional, population-based study. 

Thorisdottir IE, Agustsson G, Oskarsdottir SY, Kristjansson AL, Asgeirsdottir BB, Sigfusdottir ID, Valdimarsdottir HB, Allegrante JP, Halldorsdottir T. 

Lancet Child Adolesc Health. 2023 Mar 10:S2352-4642(23)00022-6. doi: 10.1016/S2352-4642(23)00022-6. Epub ahead of print. PMID: 36913961; PMCID: PMC10005790.


Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era. 

Carpiano RM, Callaghan T, DiResta R, Brewer NT, Clinton C, Galvani AP, Lakshmanan R, Parmet WE, Omer SB, Buttenheim AM, Benjamin RM, Caplan A, Elharake JA, Flowers LC, Maldonado YA, Mello MM, Opel DJ, Salmon DA, Schwartz JL, Sharfstein JM, Hotez PJ. 

Lancet. 2023 Mar 2:S0140-6736(23)00136-8. doi: 10.1016/S0140-6736(23)00136-8. Epub ahead of print. PMID: 36871571; PMCID: PMC9981160.


WHO's Science in 5: SARs-CoV-2 virus origins - 15 March 2023 (Video)

Science in 5 series - Episode #95 / WHO's technical lead on COVID-19 talks to us about the status of the scientific work needed to find the origins of the SARS-CoV-2 virus. Dr Maria Van Kerkhove provides an update, explains why it is important to understand the origins of pandemics, what WHO's role is in achieving this and how WHO works to prevent future pandemics. (WHO, Genf, 15.03.2023, Video, 05:55)


Surveillance of SARS-CoV-2 in the environment and animal samples of the Huanan Seafood Market, 

George Gao, William Liu, Peipei Liu et al. 

25 February 2022, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-1370392/v1]


SAGO statement on newly released SARS-CoV-2 metagenomics data from China CDC on GISAID

On 12 March 2023, WHO was made aware of new SARS-CoV-2 sequences and metagenomics data associated with samples collected in the Huanan Seafood Wholesale Market, Wuhan, China, from January 2020, that became available on GISAID for a short period of time. The data had subsequently been downloaded by a number of researchers from several countries. Access was restricted shortly after, apparently to allow further data updates by China CDC.  WHO then immediately reached out to China CDC and to the Chair and Vice-Chair of SAGO. Upon discussions between WHO and Chinese colleagues, it was explained that the genomic data are the basis for an expected update to the existing Liu et al. 2022 preprint (1), which is in the process of being re-submitted for publication to Nature by China CDC. (WHO, Genf, 18.03.2023)


WHO Director-General's opening remarks at the media briefing – 17 March 2023

Good morning, good afternoon and good evening, 

Last Saturday, the 11th of March, marked three years since WHO first described the global outbreak of COVID-19 as a pandemic. 

That was a significant moment that caught the world’s attention.  

However, from WHO’s perspective, the far more significant moment was six weeks earlier, on the 30th of January 2020, when I declared a public health emergency of international concern. (WHO, Genf, 17.03.2023)


The Impact of the COVID-19 Pandemic on Quality Education of the Medical Young Generation. 

Matasariu DR, Lozneanu L, Bujor IE, Cristofor AE, Mandici CE, Găină MA, Ștefănescu C, Boiculese VL, Popescu I, Stătescu L, Rusu A, Giusca SE, Ursache A. 

Int J Environ Res Public Health. 2023 Feb 23;20(5):3953. doi: 10.3390/ijerph20053953. PMID: 36900967; PMCID: PMC10001980.


The Fauci Phenomenon (Audio)

Rachel Gotbaum

N Engl J Med 2023; 388:e28, DOI: 10.1056/NEJMp2300937


Ärzte können weiter Coronamaske beim Personal verlangen

Düsseldorf – Auch nach dem Wegfall der allgemeinen Coronamaskenpflicht für Beschäftigte in Gesundheitseinrichtungen können Betreiber von Arztpraxen gegenteilige Anordnungen treffen. Das hat das nordrhein-westfälische Gesundheitsministerium klargestellt. (aerzteblatt.de, 06.03.2023)


SARS-CoV-2-Antigen-Schnelltests bei Beschäftigten im Gesundheitswesen - Abschätzung des Nutzens mit Hilfe einer Befragung

SARS-CoV-2 rapid antigen tests for health care workers—assessment of benefit by means of a questionnaire

Dtsch Arztebl Int 2023; 120: 170-1; DOI: 10.3238/arztebl.m2022.0412

Huzly, Erik; Steinmann, Daniel; Kramme, Stefanie; Panning, Marcus; Huzly, Daniela


Association Between Co-Occurring Anxiety and Depression With Drug Overdose Encounters in the Emergency Department Among Adolescents and Young Adults in the Era of COVID-19. 

Workman J, Reese JM, Sobalvarro S, Caberto AJ, Garcia J, Cepeda JA. 

J Adolesc Health. 2023 Jan 19:S1054-139X(23)00059-9. doi: 10.1016/j.jadohealth.2023.01.012. Epub ahead of print. PMID: 36872116; PMCID: PMC9850858.


COVID-19: Allgemeinbevölkerung zeigt hohe psychische Resilienz

Montreal – Trotz mittlerweile etwa 750 Millionen dokumentierten Erkrankungen und fast 7 Millionen Todesfällen an COVID-19 hat die Pandemie zumindest in den reicheren Ländern in der Allgemeinbevölkerung nicht zu einer Zunahme von psychischen Erkrankungen geführt. Ein „mentaler Tsunami“ ist nach einer Metaanalyse von 134 Kohortenstudien im Britischen Ärzteblatt BMJ (2023; DOI: 10.1136/bmj-2022-074224) ausgeblieben. (aerzteblatt.de, 09.03.2023)


Comparison of mental health symptoms before and during the covid-19 pandemic: evidence from a systematic review and meta-analysis of 134 cohorts.

Sun Y, Wu Y, Fan S, Dal Santo T, Li L, Jiang X, Li K, Wang Y, Tasleem A, Krishnan A, He C, Bonardi O, Boruff JT, Rice DB, Markham S, Levis B, Azar M, Thombs-Vite I, Neupane D, Agic B, Fahim C, Martin MS, Sockalingam S, Turecki G, Benedetti A, Thombs BD. 

BMJ. 2023 Mar 8;380:e074224. doi: 10.1136/bmj-2022-074224. PMID: 36889797; PMCID: PMC9992728.


Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022. 

Lee WE, Woo Park S, Weinberger DM, Olson D, Simonsen L, Grenfell BT, Viboud C. 

Elife. 2023 Feb 22;12:e77562. doi: 10.7554/eLife.77562. PMID: 36811598; PMCID: PMC9946455.


Mental disorders, COVID-19-related life-saving measures and mortality in France: A nationwide cohort study. 

Schwarzinger M, Luchini S, Teschl M, Alla F, Mallet V, Rehm J (2023) 

PLoS Med 20(2): e1004134. https://doi.org/10.1371/journal.pmed.1004134


A counterfactual analysis of opioid-involved deaths during the COVID-19 pandemic using a spatiotemporal random forest modeling approach. 

Xia Z, Stewart K. 

Health Place. 2023 Feb 7;80:102986. doi: 10.1016/j.healthplace.2023.102986. Epub ahead of print. PMID: 36774811; PMCID: PMC9902297.


Impact of COVID-19 Pandemic, Social Vulnerability, and Opioid Overdoses in Chicago. 

Knoebel RW, Kim SJ. 

AJPM Focus. 2023 Feb 10:100086. doi: 10.1016/j.focus.2023.100086. Epub ahead of print. PMID: 36789246; PMCID: PMC9911148.


Alcohol Consumption and Mental Health during the COVID-19 Pandemic. 

Yue Y, Wang S, Smith E, Goyal D, Zhu K, Zhang ZF, Smith B, Niu Z, Lei L, Freudenheim JL, Cao Y, Mu L. 

Alcohol Alcohol. 2023 Mar 1:agad011. doi: 10.1093/alcalc/agad011. Epub ahead of print. PMID: 36864564.


Chronic alcohol consumption and COVID-19 infection risk: A narrative review. 

Friske MM, Spanagel R. 

Alcohol Clin Exp Res. 2023 Feb 27. doi: 10.1111/acer.15041. Epub ahead of print. PMID: 36851826.


New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic. 

Lo Faro AF, Berardinelli D, Cassano T, Dendramis G, Montanari E, Montana A, Berretta P, Zaami S, Busardò FP, Huestis MA. 

Biology (Basel). 2023 Feb 8;12(2):273. doi: 10.3390/biology12020273. PMID: 36829550; PMCID: PMC9953068.


Depression, Anxiety and Coping Responses among Iranian Healthcare Professionals during the Coronavirus Disease (COVID-19) Outbreak. 

Etesam F, Arab Bafrani M, Akbarpour S, Tarighatnia H, Rajabi G, Dolatshahi M, Vahabi Z. 

Iran J Psychiatry. 2022 Oct;17(4):446-454. doi: 10.18502/ijps.v17i4.10694. PMID: 36817811; PMCID: PMC9922354.


The impact of COVID-19 related lockdown measures on self-reported psychopathology and health-related quality of life in German adolescents. 

Koenig J, Kohls E, Moessner M, Lustig S, Bauer S, Becker K, Thomasius R, Eschenbeck H, Diestelkamp S, Gillé V, Hiery A, Rummel-Kluge C, Kaess M; ProHEAD Consortium. 

Eur Child Adolesc Psychiatry. 2023 Jan;32(1):113-122. doi: 10.1007/s00787-021-01843-1. Epub 2021 Jul 10. PMID: 34247297; PMCID: PMC8272610.


Fast jeder zweite Coronatote aus Pflegeeinrichtung

Düsseldorf – Fast jeder zweite Coronatote in Deutschland hat offenbar in einer Pflegeeinrichtung gewohnt. Das geht aus dem Pflegereport der Barmer hervor, der der Rheinischen Post von heute vorliegt.

Bezogen auf die Jahre 2020 und 2021 liegt der gesamte Anteil der mit COVID-19 Gestorbenen demnach bei 45 Prozent. Zugleich zeigt der Report große regionale Unterschiede. (aerzteblatt.de, 28.02.2023)


Adaptation of the Tele-Harm Reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study.

Suarez E , Jr, Bartholomew TS, Plesons M, Ciraldo K, Ostrer L, Serota DP, Chueng TA, Frederick M, Onugha J, Tookes HE. 

Ann Med. 2023 Dec;55(1):733-743. doi: 10.1080/07853890.2023.2182908. PMID: 36856571; PMCID: PMC9980015.


Availability of timely methadone treatment in the United States and Canada during COVID-19: A census tract-level analysis. 

Amram O, Rosenkrantz L, DDes SA, Schuurman N, Panwala VJ, Joudrey PJ. 

Drug Alcohol Depend. 2023 Feb 9;245:109801. doi: 10.1016/j.drugalcdep.2023.109801. Epub ahead of print. PMID: 36801707; PMCID: PMC9908565.